Weekly Roundup: UnitedHealth Drops, Eli Lilly Surges, Netflix Rises
On this episode of Stock Movers:- UnitedHealth Group (UNH) shares fell the most in 26 years. The company cut its annual forecast and reported its first earnings miss in more than a decade, in a foreboding sign that weighed on other insurance stocks. UnitedHealth Group said it was blindsided by rising medical costs as the first quarter closed, upending a forecast it had affirmed just three months ago.- Eli Lilly (LLY) shares surged after its experimental pill helped patients shed weight and control blood sugar about as well as Ozempic, an advance that could turbocharge what’s already one of the fastest growing markets in medicine. The triumph of Ozempic, the blockbuster diabetes shot from Novo Nordisk A/S, and related drugs including Zepbound and Mounjaro from Lilly, has set off an all-out push to develop a pill that’s easier to take and less expensive to make. While rivals including Pfizer have suffered setbacks, analysts said success is critical to creating the $130 billion market they predict by the end of the decade.- Netflix Inc. reported first-quarter profit that exceeded Wall Street forecasts, boosted by a recent price increase and a strong slate of programming across the globe, like the hit UK series Adolescence. The owner of the world’s most popular online TV network said in a statement Thursday that earnings rose 25% to $6.61 a share, easily beating analysts’ estimates of $5.68. Sales grew 13% to $10.5 billion, in line with projections. This is the first time Netflix has reported financial results without disclosing how many customers it added or lost — the main yardstick investors previously used to gauge the company’s performance. Management is forcing investors to judge its success or failure based on more traditional financial metrics.See omnystudio.com/listener for privacy information.
--------
5:08
UnitedHealth Falls, Eli Lily Surges, FIS Strikes a Deal
On this episode of Stock Movers:- UnitedHealth Group (UNH) shares fell the most in 26 years. The company cut its annual forecast and reported its first earnings miss in more than a decade, in a foreboding sign that weighed on other insurance stocks. UnitedHealth Group said it was blindsided by rising medical costs as the first quarter closed, upending a forecast it had affirmed just three months ago. - Eli Lilly (LLY) shares surged after its experimental pill helped patients shed weight and control blood sugar about as well as Ozempic, an advance that could turbocharge what’s already one of the fastest growing markets in medicine. The triumph of Ozempic, the blockbuster diabetes shot from Novo Nordisk A/S, and related drugs including Zepbound and Mounjaro from Lilly, has set off an all-out push to develop a pill that’s easier to take and less expensive to make. While rivals including Pfizer have suffered setbacks, analysts said success is critical to creating the $130 billion market they predict by the end of the decade.- Fidelity National Information Services (FIS) shares surged while Global Payments (GPN) shares are down. This comes after the company agreed to buy rival Worldpay from GTCR and Fidelity National Information Services. Global Payments also agreed to offload its issuer-solutions business to FIS. Some analysts are skeptical of Global Payments’ ability to accelerate growth following the Worldpay acquisition, while KBW downgraded Global Payments, saying its outlook is now more complicated.See omnystudio.com/listener for privacy information.
--------
4:01
Charles Schwab Rises, DR Horton Falls, Google Drops After Ad Ruling
On this episode of Stock Movers:- Charles Schwab’s (SCHW) shares rise after it said daily average trades exceeded expectations as retail investors rushed to respond to market volatility in the first three months of the year, with company executives saying drivers of future earnings are in flux.- D.R. Horton (DHI) shares falls 1.5% after the homebuilder lowered guidance for full-year revenue; the guidance missed the average analyst estimate. Spring sales started slower than expected, cites “continued affordability constraints and declining consumer confidence”- Google (GOOGL) shares drop after a federal judge found Google guilty of illegally monopolizing online advertising technology markets for advertising exchanges and ad servers.See omnystudio.com/listener for privacy information.
--------
4:09
UnitedHealth Plunges, Eli Lilly Surges, TSMC ADRs Rise on Forecast
On this episode of Stock Movers:- UnitedHealth (UNH) shares plunge after the company cut its annual forecast and reported its first earnings miss in over a decade. The company attributed the miss to rising medical costs, particularly in Medicare Advantage health plans and its Optum Health care delivery business, which were affected by Medicare payment changes.- Eli Lilly (LLY) shares surge after data showed its experimental weight-loss pill worked as well as the Ozempic shot, bringing it one step closer to developing a needle-free alternative. The trial is one of several that Lilly is running to test the drug, called orforglipron, in diabetes, obesity and other related conditions like sleep apnea. Investors and analysts had expected it to work at least as well as Ozempic, the blockbuster diabetes shot from Novo Nordisk A/S.- TSMC (TT) ADRs rise after the chipmaker forecast sales for the second quarter that beat the average analyst estimate. The company kept its growth outlook for 2025 on expectations of AI revenue doubling.See omnystudio.com/listener for privacy information.
--------
3:33
United Health Earnings Setback; Eli Lilly Soars; TSMC Beats Forecast
On this episode of Stock Movers:- United Health (UNH) is sinking considerably this morning after it cut its full year adjusted EPS forecast and missed first quarter earnings estimates. The company cites heightened care needs in Medicare and unanticipated changes in its Optum Health care delivery business. The company expects adjusted earnings in 2025 to be $26 to $26.50 a share, down from a previous range of $29.50 to $30 a share, and the company says factors affecting earnings should be "highly addressable" this year and in 2026.- Eli Lilly (LLY) shares are soaring this morning after announcing its drug, oforglipron, became the first small molecule GLP-1 to successfully complete a Phase 3 trial.- TSMC (TSM) shares jumped this morning in premarket trading after the chipmaker forecast sales for the second quarter that beat the average analyst estimate. The company kept its growth outlook for 2025 on expectations of AI revenue doubling.- Hertz (HTZ) jumped this morning after it experienced its biggest gain ever yesterday. The upswing followed a CNBC report that stated Pershing Square Capital Management had amassed a position of almost 20% in the beleaguered car rental company. Bill Ackman’s investment firm said in a filing Wednesday that it bought 12.7 million shares valued at about $46.5 million at the time of the purchase.See omnystudio.com/listener for privacy information.
UK